Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Ind-Swift Laboratories Limited

Market Cap 11.4B 119M 103M 95.21M 89.21M 167M 170M 1.14B 440M 5.49B 447M 437M 19.1B P/E Ratio 2024
1.41x
P/E Ratio 2025 2.38x
Enterprise Value 7.13B 74.47M 64.63M 59.57M 55.82M 104M 106M 711M 275M 3.44B 280M 274M 11.95B EV / Sales 2024
0.14x
EV / Sales 2025 0.12x
Free-Float
40.56%
Yield 2024 *
-
Yield 2025 -
1 day+0.61%
1 week+1.01%
Current month+4.92%
1 month+15.85%
3 months+11.24%
6 months+63.01%
Current year+81.06%
1 week 154.2
Extreme 154.2
169.9
1 month 129.31
Extreme 129.31
173.25
Current year 87.25
Extreme 87.25
173.25
1 year 87.15
Extreme 87.15
173.25
3 years 68.72
Extreme 68.72
186
5 years 52.65
Extreme 52.65
186
10 years 15
Extreme 15
186
Manager TitleAgeSince
Chief Executive Officer 74 04/01/1995
Chief Executive Officer 43 15/06/2011
Director of Finance/CFO - 29/09/2018
Director TitleAgeSince
Director/Board Member 43 -
Chairman 74 -
Director/Board Member 35 23/03/2010
Date Insider Type Main position Quantity % Market Cap.
12/09/24Sell

Chief Financial Officer

30,000 0.0508%
Change 5-day change 1-year change 3-year change Capi.($)
+0.83%+1.01%+44.75%+128.82% 144M
+0.67%+1.35%+7.05%+83.30% 44.96B
-0.64%-4.06%+37.33%+86.34% 33.53B
+0.54%-0.76%-7.46%+44.87% 11.67B
+0.85%+2.48%+14.02%+118.82% 11.62B
+0.88%+0.78%+37.07%+126.43% 8.97B
-1.44%-1.94%+15.12%+39.35% 6.89B
-1.85%-1.42%+38.92%-19.30% 6.55B
-0.44%-1.50%+30.13%+234.13% 6.32B
-0.45%-2.96%-39.97%-6.82% 5.12B
Average -0.14%-0.67%+17.69%+83.59% 13.58B
Weighted average by Cap. +0.03%-1.10%+17.15%+83.13%

Financials

2024 2025
Net sales 12.97B 135M 118M 108M 102M 190M 194M 1.29B 501M 6.25B 509M 498M 21.74B 5.62B 58.66M 50.91M 46.93M 43.97M 82.15M 83.87M 560M 217M 2.71B 220M 215M 9.41B
Net income 4.21B 43.96M 38.15M 35.17M 32.95M 61.57M 62.85M 420M 162M 2.03B 165M 161M 7.06B 2.5B 26.16M 22.7M 20.93M 19.61M 36.63M 37.4M 250M 96.64M 1.21B 98.2M 96.09M 4.2B
Net Debt -4.15B -43.37M -37.64M -34.7M -32.51M -60.74M -62.01M -414M -160M -2B -163M -159M -6.96B -4.27B -44.55M -38.66M -35.63M -33.39M -62.39M -63.69M -425M -165M -2.06B -167M -164M -7.15B
Logo Ind-Swift Laboratories Limited
Ind-Swift Laboratories Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (APIs), intermediates and formulations. The Company operates in the Pharmaceutical Business segment. It also focuses on manufacturing formulations. The Company’s products include APIs and Impurities. Its APIs therapeutic category includes Macrolide Antibiotic, Cardiovascular, Antihistaminic, Antidiabetic, Antipsyhotic, Bone Resorption Inhibitor, and Aromatase Inhibitor. Its products include Clarithromycin, Clarithromycin Coated Granules, Clarithromycin Citrate, Atorvastatin Calcium Crystalline, Atorvastatin Calcium Amorphous, Clopidogrel HCl, Ezetimibe, Ivabradine Oxalate, Ranolazine, Aripiprazole, Risedronate Sodium, Ropinirole HCl, Cinacalcet HCl, Letrozole, and Anastrozole. Its products under development include Sitagliptin Phosphate, Mirabegron, Bempedoic Acid, Lasmiditan, and Eltrombopag Olamine.
Employees
1,246
Date Price Change Volume
12/06/26 159.95 +0.83% 88,326
11/06/26 158.63 -2.60% 566,933
10/06/26 162.86 +0.61% 1,351,221
09/06/26 161.87 +3.27% 1,700,677
08/06/26 156.74 -0.80% 848,615
  1. Stock Market
  2. Stocks
  3. INDSWFTLAB Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!